We are live on !
Find out more
John Paulson Paulson & Co
AUM
$2.58B
Turnover
30%
1-Year Est. Return
68.51%
John Paulson is the founder of Paulson & Co., a firm that became world-famous for profits related to the 2007–2008 housing and credit crisis. Beyond that landmark trade, the firm has pursued merger arbitrage, event-driven, and opportunistic credit and equity strategies. Paulson remains one of the most recognized names in modern hedge fund history.
This Fund
S&P 500
This Quarter Est. Return
+0.36%
1 Year Est. Return
+68.51%
3 Year Est. Return
+251.48%
5 Year Est. Return
+229.81%
10 Year Est. Return
+881.28%
AUM
$9.8B
AUM Growth
-$3.69B
(-27%)
Cap. Flow
-$3.22B
Cap. Flow % of AUM
Cap. Flow %
-32.77%
Top 10 Holdings %
Top 10 Hldgs %
67.19%
Holding
109
New
12
Increased
20
Reduced
31
Closed
23
Avg Time Held
Equity + Options
1.3
years
Top 10 Avg Time Held
Equity + Options
0.9
years
Top 20 Avg Time Held
Equity + Options
1.1
years
Avg Time Held Equity only
1.3
years
Top 10 Avg Time Held Equity only
0.9
years
Top 20 Avg Time Held Equity only
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC CORPORATION
EMC
|
+$271M |
| 2 |
Bausch Health
BHC
|
+$164M |
| 3 |
VMW
VMware, Inc
VMW
|
+$114M |
| 4 |
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
|
+$56.5M |
| 5 |
ODP
ODP
|
+$38.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$560M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$370M |
| 3 |
Lam Research
LRCX
|
+$368M |
| 4 |
AGN
Allergan plc
AGN
|
+$339M |
| 5 |
SHPG
Shire pic
SHPG
|
+$339M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 55.49% |
| 2 | Consumer Discretionary | 10.42% |
| 3 | Miscellaneous | 10.25% |
| 4 | Materials | 5.74% |
| 5 | Financials | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SHPG
1
DELISTED
Shire pic
SHPG
| $956M | 9.72% |
5,194,600
-1,876,450
| -27% | -$339M |
2013 Q2
12 quarters
|
|
2
Viatris
VTRS
$21.2B
| $952M | 9.68% |
22,028,061
-1,307,800
| -6% | -$57.9M |
2013 Q2
12 quarters
|
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $912M | 9.28% |
3,948,451
-1,469,849
| -27% | -$339M |
2014 Q1
9 quarters
|
|
4
Teva Pharmaceutical Industries Limited
TEVA
$46.8B
| $843M | 8.56% |
16,773,800
-3,828,400
| -19% | -$204M |
2015 Q2
4 quarters
|
|
|
STAY
5
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $638M | 6.48% |
42,661,591
| – | – |
2013 Q4
10 quarters
|
|
6
SPDR Gold Trust
GLD
$136B
| $604M | 6.14% |
4,775,012
| – | – |
2013 Q2
12 quarters
|
|
|
MNK
7
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $509M | 5.17% |
8,371,080
-578,300
| -6% | -$35.3M |
2013 Q3
11 quarters
|
|
8
American International
AIG
$43.3B
| $479M | 4.87% |
9,060,100
-2,172,700
| -19% | -$120M |
2015 Q1
5 quarters
|
|
|
9
Bausch Health
BHC
$2.42B
| $384M | 3.9% |
19,072,000
+5,787,200
| +44% | +$164M |
2014 Q1
9 quarters
|
|
|
HOT
10
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $333M | 3.38% |
4,496,476
-1,035,524
| -19% | -$79.5M |
2015 Q2
4 quarters
|
|
|
11
DELISTED
EMC CORPORATION
EMC
| $273M | 2.77% |
+10,045,606
| New | +$271M |
2016 Q2
0 quarters
|
|
|
AKRX
12
DELISTED
Akorn Inc
AKRX
| $257M | 2.61% |
9,012,900
-305,700
| -3% | -$8.47M |
2015 Q4
2 quarters
|
|
13
AngloGold Ashanti
AU
$42.9B
| $232M | 2.35% |
12,820,100
-2,402,300
| -16% | -$36.6M |
2013 Q2
12 quarters
|
|
14
NovaGold Resources
NG
$2.72B
| $157M | 1.6% |
25,705,396
-9,810,661
| -28% | -$58.5M |
2013 Q2
12 quarters
|
|
|
CACQ
15
DELISTED
Caesars Acquisition Company
CACQ
| $147M | 1.5% |
13,141,098
| – | – |
2013 Q4
10 quarters
|
|
|
ENDP
16
DELISTED
Endo International plc
ENDP
| $140M | 1.42% |
8,956,300
-561,200
| -6% | -$11.6M |
2015 Q3
3 quarters
|
|
17
DELISTED
Anywhere Real Estate
HOUS
| $139M | 1.41% |
4,785,000
-475,000
| -9% | -$15.6M |
2013 Q2
12 quarters
|
|
18
Grifois
GRFS
$5.06B
| $122M | 1.24% |
7,345,166
-10,188,598
| -58% | -$160M |
2013 Q2
12 quarters
|
|
|
VMW
19
DELISTED
VMware, Inc
VMW
| $113M | 1.15% |
+1,972,100
| New | +$114M |
2016 Q2
0 quarters
|
|
20
DELISTED
Caesars Entertainment Corporation
CZR
| $111M | 1.13% |
14,441,000
| – | – |
2013 Q2
12 quarters
|
|
|
SGYP
21
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $105M | 1.07% |
27,756,668
+16,666,668
| +150% | +$56.5M |
2015 Q1
5 quarters
|
|
22
Agnico Eagle Mines
AEM
$88.8B
| $67.4M | 0.69% |
1,260,600
| – | – |
2013 Q2
12 quarters
|
|
|
ACAS
23
DELISTED
American Capital Ltd
ACAS
| $66.9M | 0.68% |
4,224,900
+250,000
| +6% | +$3.95M |
2016 Q1
1 quarter
|
|
24
TIM SA
TIMB
$9.25B
| $61.8M | 0.63% |
5,860,300
-109,700
| -2% | -$1.12M |
2014 Q2
8 quarters
|
|
25
DELISTED
Randgold Resources Ltd
GOLD
| $56M | 0.57% |
500,000
| – | – |
2013 Q2
12 quarters
|
|
Similar funds
CL
John Paulson's Q2 2016 Portfolio in Review
As of Q2 2016, John Paulson held 109 positions worth $9.8B, down 27% from $13.5B the previous quarter. Its ten largest holdings account for 67% of the portfolio.
John Paulson withdrew a net $3.22B in Q2 2016, closing 23 positions and reducing 31 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $370M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 54% a quarter earlier, followed by Consumer Discretionary and Miscellaneous.
Against the trend, John Paulson opened a new position in EMC CORPORATION worth $273M.
- John Paulson's largest Q2 2016 buy was EMC CORPORATION: 10,045,606 shares worth $273M.
- John Paulson added most to Bausch Health in Q2 2016, an estimated $164M increase.
- John Paulson's biggest Q2 2016 reduction was T-Mobile US, cutting an estimated $560M.
- John Paulson fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $370M.
- John Paulson's ten largest holdings make up 67% of its $9.8B portfolio in Q2 2016.
- John Paulson opened 12 new positions and closed 23 in Q2 2016.
- John Paulson's portfolio value fell 27% quarter-over-quarter to $9.8B.
Based on Paulson & Co's 13F filing for Q2 2016, filed 15 Aug 2016.